Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashwini Kumar

Showing results (381-390 of 387) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 387 results.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
The New England Journal of Medicine|January 8, 2025
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple MyelomaYael C Cohen, Hila Magen, Moshe Gatt, et al.
Cancer Discovery|November 18, 2021
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid LeukemiaDisha Malani, Ashwini Kumar, Oscar Brück, et al.
F1000Research|July 16, 2019
Are we missing 'previously treated' smear-positive pulmonary tuberculosis under programme settings in India? A cross-sectional studyHemant Deepak Shewade, Vivek Gupta, Srinath Satyanarayana, et al.
Plos One|March 14, 2019
Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in IndiaHemant Deepak Shewade, Vivek Gupta, Srinath Satyanarayana, et al.
Global Health Action|September 4, 2018
Active case finding among marginalised and vulnerable populations reduces catastrophic costs due to tuberculosis diagnosisHemant Deepak Shewade, Vivek Gupta, Srinath Satyanarayana, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|May 5, 2026
Toward a United Arab Emirates national inflammatory bowel disease transition care pathway: Findings from a healthcare professional survey and development of evidence-based toolsMohammed N Quraishi, Rana Bitar, Sara El Ouali, et al.
Pageof 39

Showing results (381-390 of 387) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 387 results.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
The New England Journal of Medicine|January 8, 2025
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple MyelomaYael C Cohen, Hila Magen, Moshe Gatt, et al.
Cancer Discovery|November 18, 2021
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid LeukemiaDisha Malani, Ashwini Kumar, Oscar Brück, et al.
F1000Research|July 16, 2019
Are we missing 'previously treated' smear-positive pulmonary tuberculosis under programme settings in India? A cross-sectional studyHemant Deepak Shewade, Vivek Gupta, Srinath Satyanarayana, et al.
Plos One|March 14, 2019
Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in IndiaHemant Deepak Shewade, Vivek Gupta, Srinath Satyanarayana, et al.
Global Health Action|September 4, 2018
Active case finding among marginalised and vulnerable populations reduces catastrophic costs due to tuberculosis diagnosisHemant Deepak Shewade, Vivek Gupta, Srinath Satyanarayana, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|May 5, 2026
Toward a United Arab Emirates national inflammatory bowel disease transition care pathway: Findings from a healthcare professional survey and development of evidence-based toolsMohammed N Quraishi, Rana Bitar, Sara El Ouali, et al.
Pageof 39